Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Limited Evidence for the Need for Region-Specific, Genotypic Drug-Susceptibility Assays for Mycobacterium tuberculosis.

Köser CU, Koeser LA, Dolinger DL.

Clin Infect Dis. 2018 Apr 17;66(9):1481-1482. doi: 10.1093/cid/cix1042. No abstract available.

PMID:
29182771
2.

FIND Tuberculosis Strain Bank: a Resource for Researchers and Developers Working on Tests To Detect Mycobacterium tuberculosis and Related Drug Resistance.

Tessema B, Nabeta P, Valli E, Albertini A, Collantes J, Lan NH, Romancenco E, Tukavdze N, Denkinger CM, Dolinger DL.

J Clin Microbiol. 2017 Apr;55(4):1066-1073. doi: 10.1128/JCM.01662-16. Epub 2017 Jan 18.

3.

A sensitive and specific point-of-care detection assay for Zaire Ebola virus.

Zhang XA, Li S, Ching J, Feng HY, Yang K, Dolinger DL, Zhang LD, Zhang PH, Liu W, Cao WC.

Emerg Microbes Infect. 2017 Jan 18;6(1):e5. doi: 10.1038/emi.2016.134. No abstract available.

4.

Next-generation sequencing-based user-friendly platforms for drug-resistant tuberculosis diagnosis: A promise for the near future.

Dolinger DL, Colman RE, Engelthaler DM, Rodwell TC.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S27-S28. doi: 10.1016/j.ijmyco.2016.09.021. Epub 2016 Oct 28.

5.

Target Product Profile for a Diagnostic Assay to Differentiate between Bacterial and Non-Bacterial Infections and Reduce Antimicrobial Overuse in Resource-Limited Settings: An Expert Consensus.

Dittrich S, Tadesse BT, Moussy F, Chua A, Zorzet A, Tängdén T, Dolinger DL, Page AL, Crump JA, D'Acremont V, Bassat Q, Lubell Y, Newton PN, Heinrich N, Rodwell TJ, González IJ.

PLoS One. 2016 Aug 25;11(8):e0161721. doi: 10.1371/journal.pone.0161721. eCollection 2016.

6.

Analytical and Clinical Evaluation of the Epistem Genedrive Assay for Detection of Mycobacterium tuberculosis.

Shenai S, Armstrong DT, Valli E, Dolinger DL, Nakiyingi L, Dietze R, Dalcolmo MP, Nicol MP, Zemanay W, Manabe Y, Hadad DJ, Marques-Rodrigues P, Palaci M, Peres RL, Gaeddert M, Armakovitch S, Nonyane BA, Denkinger CM, Banada P, Joloba ML, Ellner J, Boehme C, Alland D, Dorman SE.

J Clin Microbiol. 2016 Apr;54(4):1051-7. doi: 10.1128/JCM.02847-15. Epub 2016 Feb 10.

7.

A Collaborative Approach for "ReSeq-ing" Mycobacterium tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers.

Schito M, Dolinger DL.

EBioMedicine. 2015 Oct 9;2(10):1262-5. doi: 10.1016/j.ebiom.2015.10.008. eCollection 2015 Oct. No abstract available.

8.

Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform.

Starks AM, Avilés E, Cirillo DM, Denkinger CM, Dolinger DL, Emerson C, Gallarda J, Hanna D, Kim PS, Liwski R, Miotto P, Schito M, Zignol M.

Clin Infect Dis. 2015 Oct 15;61Suppl 3:S141-6. doi: 10.1093/cid/civ610.

9.

Integration of published information into a resistance-associated mutation database for Mycobacterium tuberculosis.

Salamon H, Yamaguchi KD, Cirillo DM, Miotto P, Schito M, Posey J, Starks AM, Niemann S, Alland D, Hanna D, Aviles E, Perkins MD, Dolinger DL.

J Infect Dis. 2015 Apr 1;211 Suppl 2:S50-7. doi: 10.1093/infdis/jiu816. Review.

10.

The second peptidoglycan hydrolase of Streptococcus faecium ATCC 9790 covalently binds penicillin.

Dolinger DL, Daneo-Moore L, Shockman GD.

J Bacteriol. 1989 Aug;171(8):4355-61.

11.
12.

The autolytic peptidoglycan hydrolases of Streptococcus faecium.

Shockman GD, Kawamura T, Barrett JF, Dolinger DL.

Ann Inst Pasteur Microbiol (1985). 1985 Jan-Feb;136A(1):63-6.

PMID:
2860842
13.

The mechanism of soluble peptidoglycan hydrolysis by an autolytic muramidase. A processive exodisaccharidase.

Barrett JF, Dolinger DL, Schramm VL, Shockman GD.

J Biol Chem. 1984 Oct 10;259(19):11818-27.

Supplemental Content

Loading ...
Support Center